Overview
- 20 inspections across 19 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-03-06.
At a glance
Inspections
20
Sites
19
Observations
8
Career since
Mar 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| MEDPHARM LTD | 6 Mar 2020 | Human Drugs | |
| Eurofins Pharma Bioanalysis Services Uk Ltd | 28 Feb 2020 | Human Drugs | |
| QPS, LLC | 10 Jan 2020 | Human Drugs | |
| Amphastar Pharmaceuticals, Inc. | 22 Nov 2019 | Human Drugs | |
| RiconPharma LLC | 13 Sep 2019 | Human Drugs |
Sites inspected
MEDPHARM LTDGuildford, United Kingdom1 insp.
Eurofins Pharma Bioanalysis Services Uk LtdAbingdon, United Kingdom1 insp.
QPS, LLCFargo, United States1 insp.
Amphastar Pharmaceuticals, Inc.Rancho Cucamonga, United States1 insp.
RiconPharma LLCDenville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Mohsen Rajabi Abhari2 shared
Peter R Lenahan2 shared
Seongeun Cho1 shared
John A Kadavil1 shared
Vanessa E Coulter1 shared
Lakecha N Lewis1 shared
Xiaohan Cai1 shared
Amanda Jones1 shared
Stephanie C Mangigian1 shared
Stanley Au1 shared
Full investigator report
Get the verbatim findings behind Himanshu Gupta's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site